ChemicalBook--->CAS DataBase List--->1688684-07-2

1688684-07-2

1688684-07-2 Structure

1688684-07-2 Structure
IdentificationBack Directory
[Name]

5-[[[(3-Chloro-4-fluorophenyl)sulfonyl]amino]methyl]-N-[(2-methyl-5-thiazolyl)methyl]-2-pyrazinecarboxamide
[CAS]

1688684-07-2
[Synonyms]

5-[[[(3-Chloro-4-fluorophenyl)sulfonyl]amino]methyl]-N-[(2-methyl-5-thiazolyl)methyl]-2-pyrazinecarboxamide
[Molecular Formula]

C17H15ClFN5O3S2
[MOL File]

1688684-07-2.mol
[Molecular Weight]

455.92
Chemical PropertiesBack Directory
[density ]

1.502±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
[pka]

7.58±0.50(Predicted)
Hazard InformationBack Directory
[Uses]

MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1].
[IC 50]

NMDA Receptor
[References]

[1] Robert A Volkmann, et al. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. PLoS One. 2016 Feb 1;11(2):e0148129. DOI:10.1371/journal.pone.0148129
1688684-07-2 suppliers list
Company Name: Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd  
Tel: 025-58851090 17714375163
Website: https://www.aikonchem.com/
Tags:1688684-07-2 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.